EUVIMEDEUVIMED entdecken
Crossref

132 HiJacK vitiligo: JAK3 and TEC family kinase inhibition in the pathogenesis and treatment of vitiligo

Emma Holtappels, Saskia Chielie, Nathalie van Uden, Tessa Licher, Marcel Bekkenk, Rosalie Luiten, Walbert Bakker

Journal of Investigative Dermatology · 2025-11 · 145 (11) · e52

DOI: 10.1016/j.jid.2025.09.147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Emma Holtappels und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Holtappels, E., Chielie, S., Uden, N. V., Licher, T., Bekkenk, M., Luiten, R., & Bakker, W. (2025). 132 HiJacK vitiligo: JAK3 and TEC family kinase inhibition in the pathogenesis and treatment of vitiligo. Journal of Investigative Dermatology, 145(11), e52. https://doi.org/10.1016/j.jid.2025.09.147

Vancouver

Holtappels E, Chielie S, Uden NV, Licher T, Bekkenk M, Luiten R, et al. 132 HiJacK vitiligo: JAK3 and TEC family kinase inhibition in the pathogenesis and treatment of vitiligo. Journal of Investigative Dermatology. 2025;145(11):e52. doi:10.1016/j.jid.2025.09.147

BibTeX
@article{Holtappels2025,
  author = {Holtappels, Emma and Chielie, Saskia and Uden, Nathalie van and Licher, Tessa and Bekkenk, Marcel and Luiten, Rosalie and Bakker, Walbert},
  title = {132 HiJacK vitiligo: JAK3 and TEC family kinase inhibition in the pathogenesis and treatment of vitiligo},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {11},
  pages = {e52},
  doi = {10.1016/j.jid.2025.09.147}
}
Kostenlos starten →